Duque, A.E.D.; Ferrari, P.S.S.M.; Ethiraj, P.; Jaafar, C.; Qiu, Z.; Holder, K.; Butler, M.J.; Huelgas-Morales, G.; Karnad, A.; Dahia, P.L.M.;
et al. First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL. Cancers 2024, 16, 3857.
https://doi.org/10.3390/cancers16223857
AMA Style
Duque AED, Ferrari PSSM, Ethiraj P, Jaafar C, Qiu Z, Holder K, Butler MJ, Huelgas-Morales G, Karnad A, Dahia PLM,
et al. First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL. Cancers. 2024; 16(22):3857.
https://doi.org/10.3390/cancers16223857
Chicago/Turabian Style
Duque, Adolfo E. Diaz, Pedro S. S. M. Ferrari, Purushoth Ethiraj, Carine Jaafar, Zhijun Qiu, Kenneth Holder, Mathew J. Butler, Gabriela Huelgas-Morales, Anand Karnad, Patricia L. M. Dahia,
and et al. 2024. "First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL" Cancers 16, no. 22: 3857.
https://doi.org/10.3390/cancers16223857
APA Style
Duque, A. E. D., Ferrari, P. S. S. M., Ethiraj, P., Jaafar, C., Qiu, Z., Holder, K., Butler, M. J., Huelgas-Morales, G., Karnad, A., Dahia, P. L. M., & Aguiar, R. C. T.
(2024). First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL. Cancers, 16(22), 3857.
https://doi.org/10.3390/cancers16223857
